Latest Breaking News On - Phenomex inc - Page 1 : vimarsana.com

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesSteve williamsonJohn mckuneBrian johnstonPulmonx zephyrMehul joshiGilmartin groupPulmonx corporationRutgers universityRutgers graduate school of managementSecurities exchangePulmonx corporation nasdaqPhenomex incGilead sciences incOperations finance at gilead sciencesExchange commission

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSteve williamsonJohn mckuneBrian johnstonPulmonx zephyrMehul joshiGilead sciences incPulmonx corporation nasdaqGilmartin groupPulmonx corporationMaster of business administrationPrior to phenomex incPhenomex incExchange commissionResmed incSecurities exchange

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPulmonx zephyrBrian johnstonJohn mckuneMehul joshiSteve williamsonPhenomex incExchange commissionRutgers graduate school of managementRutgers universitySecurities exchangeResmed incOperations finance at gilead sciencesGilmartin groupPulmonx corporation nasdaqGilead sciences inc

Bruker acquires molecular diagnostics provider Elitech for €870M

Continuing its aggressive buying spree, Bruker Corp. entered into a definitive share purchase agreement with Tecfin S.à r.l. to acquire molecular diagnostics (MDx) company Elitechgroup SAS for €870 million (US$943.5 million), excluding the Elitech clinical chemistry business. The deal is expected to close in the second quarter of 2024 and will be funded with a mix of cash on hand and debt financing.

Bruker corpBioworld medtechInfectious diseasesBruker corpTornado spectral systems incNion llcNanophoton corpChemspeed technologies agPhasefocus holdings ltdPhenomex incZontal incMolecular diagnosticsIn vitro diagnostics

Bruker Reports Fourth Quarter and Full Year 2023 Financial Results

Q4 2023 revenues of $854.5 million, up 20.6% year-over-year ; organic revenue up 15.9% yoy Q4 2023 GAAP EPS of $1.41, including a $0.99 per share gain on PhenomeX acquisition[1]; Q4 2023.

United statesBruker nanoFrank laukienBruker biospinAsia pacificSecurities exchangeBruker corporation nasdaqExchange commissionBruker corporationBruker energy supercon technologiesPhenomex incScientific instrumentsSupercon technologiesEastern standardInvestor relationsFourth quarter